Botulinum Toxin in Movement Disorders

Overview of attention for article published in Seminars in Neurology, April 2007

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

patent: 10 patents

wikipedia: 3 Wikipedia pages

Readers on

mendeley: 21 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 10 patents that reference this research output.

Botulinum toxin and the treatment of primary disorders of mood and affect

Grant US-10441641-B2

United States of America

15 Oct 2019

Anticonvulsant combination therapy

Grant US-9446011-B2

United States of America

20 Sep 2016

Anticonvulsant combination therapy

Grant US-9095557-B2

United States of America

04 Aug 2015

Botulinum toxin and the treatment of primary disorders of mood and affect

Grant US-8926991-B2

United States of America

06 Jan 2015

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 6 additional patents.